| Old | New | Differences | |
|---|---|---|---|
| 1 | 1 | 87R1451 GCB-D | |
| 2 | 2 | By: Lucio III H.B. No. 1001 | |
| 3 | 3 | ||
| 4 | 4 | ||
| 5 | 5 | A BILL TO BE ENTITLED | |
| 6 | 6 | AN ACT | |
| 7 | 7 | relating to the medical use of low-THC cannabis by certain patients | |
| 8 | 8 | with post-traumatic stress disorder under the Texas Compassionate | |
| 9 | 9 | Use Act. | |
| 10 | 10 | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| 11 | 11 | SECTION 1. Section 169.003, Occupations Code, is amended to | |
| 12 | 12 | read as follows: | |
| 13 | 13 | Sec. 169.003. PRESCRIPTION OF LOW-THC CANNABIS. A physician | |
| 14 | 14 | described by Section 169.002 may prescribe low-THC cannabis to a | |
| 15 | 15 | patient if: | |
| 16 | 16 | (1) the patient is a permanent resident of the state; | |
| 17 | 17 | (2) the physician complies with the registration | |
| 18 | 18 | requirements of Section 169.004; and | |
| 19 | 19 | (3) the physician certifies to the department that: | |
| 20 | 20 | (A) the patient is diagnosed with: | |
| 21 | 21 | (i) epilepsy; | |
| 22 | 22 | (ii) a seizure disorder; | |
| 23 | 23 | (iii) multiple sclerosis; | |
| 24 | 24 | (iv) spasticity; | |
| 25 | 25 | (v) amyotrophic lateral sclerosis; | |
| 26 | 26 | (vi) autism; | |
| 27 | 27 | (vii) terminal cancer; [or] | |
| 28 | 28 | (viii) an incurable neurodegenerative | |
| 29 | 29 | disease; or | |
| 30 | 30 | (ix) post-traumatic stress disorder; and | |
| 31 | 31 | (B) the physician determines the risk of the | |
| 32 | 32 | medical use of low-THC cannabis by the patient is reasonable in | |
| 33 | 33 | light of the potential benefit for the patient. | |
| 34 | 34 | SECTION 2. This Act takes effect September 1, 2021. |